Homeodomain-only protein homeobox (HOPX) expression in the human placenta: a new actor in maternal fetal tolerance during gestation?

HOPX (homeodomain-only protein), a member of the homeodomain family, is involved in various developmental processes and immune regulation. This study highlights HOPX expression in human placenta and its potential role in modulating maternal immune responses during pregnancy. Twenty-four human placental samples, ranging from 11 to 40 weeks of gestation, were analyzed using immunohistochemistry to analyze HOPX expression. The results showed that HOPX was expressed predominantly in the syncytiotrophoblasts of placental villi, with heterogeneus distribution of immunoreactivity. In some placentas, HOPX was uniformly expressed across villi, while in others expression was absent. No significant expression of HOPX was observed in cytotrophoblasts, Hofbauer cells, or developing vascular structures. HOPX may play a key role in promoting maternal immune tolerance by modulating the activity of maternal T-cells in the placental interface. The variability in HOPX expression could indicate its involvement in pathological conditions, such as maternal non-acceptance of the fetus, and may be linked to pregnancy complications. Furthermore, the presence of HOPX in the nuclei of syncytiotrophoblasts underscores its potential role as a transcription factor involved in placental development and immune regulation. This study provides novel insights into the role of HOPX in maintaining maternal-fetal immune tolerance and highlights the need for further investigation into its involvement in pregnancy-related immune responses and complications.